QS-21: A Potent Vaccine Adjuvant

Overview

Journal Nat Prod Chem Res

Publisher Omics Publishing Group

Date 2016 May 24

PMID 27213168

Citations 36

Authors

Daming Zhu

Wenbin Tuo

Affiliations

Soon will be listed here.

Citing Articles

Enhancing vaccine effectiveness in the elderly to counter antibiotic resistance: The potential of adjuvants via pattern recognition receptors.

Jung M, Kim H, Choi E, Shin M, Shin S Hum Vaccin Immunother. 2024; 20(1):2317439.

PMID: 39693178 PMC: 10913723. DOI: 10.1080/21645515.2024.2317439.

Current Progress in the Science of Novel Adjuvant Nano-Vaccine-Induced Protective Immune Responses.

Saleemi M, Zhang Y, Zhang G Pathogens. 2024; 13(6).

PMID: 38921739 PMC: 11206999. DOI: 10.3390/pathogens13060441.

Controlled Lipid Self-Assembly for Scalable Manufacturing of Next-Generation Immune Stimulating Complexes.

Pires I, Ni K, Melo M, Li N, Ben-Akiva E, Maiorino L Chem Eng J. 2024; 464.

PMID: 38737525 PMC: 11081102. DOI: 10.1016/j.cej.2023.142664.

A spike virosome vaccine induces pan-sarbecovirus antibody responses in mice.

Brinkkemper M, Poniman M, Rijnstra E, Iddouch W, Bijl T, Guerra D iScience. 2024; 27(5):109719.

PMID: 38706848 PMC: 11068555. DOI: 10.1016/j.isci.2024.109719.

Vaccine Strategies to Elicit Mucosal Immunity.

Song Y, Mehl F, Zeichner S Vaccines (Basel). 2024; 12(2.

PMID: 38400174 PMC: 10892965. DOI: 10.3390/vaccines12020191.

References

OHagan D, MacKichan M, Singh M . Recent developments in adjuvants for vaccines against infectious diseases. Biomol Eng. 2001; 18(3):69-85. DOI: 10.1016/s1389-0344(01)00101-0. View

Liu G, Anderson C, Scaltreto H, Barbon J, Kensil C . QS-21 structure/function studies: effect of acylation on adjuvant activity. Vaccine. 2002; 20(21-22):2808-15. DOI: 10.1016/s0264-410x(02)00209-8. View

Dalsgaard K, Jensen M, Sorensen K . Saponin adjuvants. IV. Evaluation of the adjuvant quil A in the vaccination of cattle against foot-and-mouth disease. Acta Vet Scand. 1977; 18(3):349-60. PMC: 8377628. View

Dalsgaard K . Saponin adjuvants. 3. Isolation of a substance from Quillaja saponaria Molina with adjuvant activity in food-and-mouth disease vaccines. Arch Gesamte Virusforsch. 1974; 44(3):243-54. View

Borja-Cabrera G, Correia Pontes N, da Silva V, Paraguai de Souza E, Santos W, GOMES E . Long lasting protection against canine kala-azar using the FML-QuilA saponin vaccine in an endemic area of Brazil (São Gonçalo do Amarante, RN). Vaccine. 2002; 20(27-28):3277-84. DOI: 10.1016/s0264-410x(02)00294-3. View

Marciani D, Kensil C, Beltz G, Hung C, Cronier J, Aubert A . Genetically-engineered subunit vaccine against feline leukaemia virus: protective immune response in cats. Vaccine. 1991; 9(2):89-96. DOI: 10.1016/0264-410x(91)90262-5. View

Garcon N, Chomez P, Van Mechelen M . GlaxoSmithKline Adjuvant Systems in vaccines: concepts, achievements and perspectives. Expert Rev Vaccines. 2007; 6(5):723-39. DOI: 10.1586/14760584.6.5.723. View

Katayama S, Oda K, Ohgitani T, Hirahara T, Shimizu Y . Influence of antigenic forms and adjuvants on the IgG subclass antibody response to Aujeszky's disease virus in mice. Vaccine. 1999; 17(20-21):2733-9. DOI: 10.1016/s0264-410x(98)00499-x. View

Sun H, Xie Y, Ye Y . Advances in saponin-based adjuvants. Vaccine. 2009; 27(12):1787-96. DOI: 10.1016/j.vaccine.2009.01.091. View

10.

Singh M, OHagan D . Recent advances in veterinary vaccine adjuvants. Int J Parasitol. 2003; 33(5-6):469-78. DOI: 10.1016/s0020-7519(03)00053-5. View

11.

Aguilar J, Rodriguez E . Vaccine adjuvants revisited. Vaccine. 2007; 25(19):3752-62. DOI: 10.1016/j.vaccine.2007.01.111. View

12.

Campbell J, Peerbaye Y . Saponin. Res Immunol. 1992; 143(5):526-30;discussion 577-8. DOI: 10.1016/0923-2494(92)80064-r. View

13.

Kirk D, Rempel R, Pinkhasov J, Walmsley A . Application of Quillaja saponaria extracts as oral adjuvants for plant-made vaccines. Expert Opin Biol Ther. 2004; 4(6):947-58. DOI: 10.1517/14712598.4.6.947. View

14.

Kersten G, Hirschberg H . Antigen delivery systems. Expert Rev Vaccines. 2004; 3(4):453-62. DOI: 10.1586/14760584.3.4.453. View

15.

Song X, Hu S . Adjuvant activities of saponins from traditional Chinese medicinal herbs. Vaccine. 2009; 27(36):4883-90. DOI: 10.1016/j.vaccine.2009.06.033. View

16.

Dalsgaard . A study of the isolation and characterization of the saponin Quil A. Evaluation of its adjuvant activity, with a special reference to the application in the vaccination of cattle against foot-and-mouth disease. Acta Vet Scand Suppl. 1978; (69):7-40. View

17.

Garcon N, Van Mechelen M . Recent clinical experience with vaccines using MPL- and QS-21-containing adjuvant systems. Expert Rev Vaccines. 2011; 10(4):471-86. DOI: 10.1586/erv.11.29. View

18.

Lee S, Nguyen M . Recent advances of vaccine adjuvants for infectious diseases. Immune Netw. 2015; 15(2):51-7. PMC: 4411509. DOI: 10.4110/in.2015.15.2.51. View

19.

Warshakoon H, Hood J, Kimbrell M, Malladi S, Wu W, Shukla N . Potential adjuvantic properties of innate immune stimuli. Hum Vaccin. 2009; 5(6):381-94. DOI: 10.4161/hv.5.6.8175. View

20.

Kensil C, Patel U, Lennick M, Marciani D . Separation and characterization of saponins with adjuvant activity from Quillaja saponaria Molina cortex. J Immunol. 1991; 146(2):431-7. View